KLOW Blend
Proprietary four-peptide research formulation for multi-pathway laboratory investigation.
KLOW is a proprietary four-peptide research formulation combining BPC-157, TB-500, GHK-Cu, and KPV for studies examining cellular communication, extracellular matrix biology, tissue remodeling, and peptide interaction.
Available Format
Selected Price Option
Select Delivery Terms
Strictly for laboratory research use only. Not for human or animal consumption.
Research Pathways & Mechanisms
BPC-157
A synthetic research peptide investigated across numerous preclinical laboratory models for its relationship to angiogenic signaling pathways, connective tissue biology, and gastrointestinal research.
Studying how this peptide behaves in tissue-repair and connective-tissue research models.
TB-500
Commonly associated with thymosin beta-4 research, studied for its role in cell migration, actin regulation, angiogenesis, and tissue-remodeling pathways.
Looking at how cells move, organize, and respond in preclinical tissue-model research.
GHK-Cu
A naturally occurring copper-binding tripeptide studied in extracellular matrix biology, collagen and glycosaminoglycan synthesis, cellular signaling, and gene-expression research.
Exploring how copper-peptide signaling supports structural tissue research.
KPV
A tripeptide (Lys-Pro-Val) corresponding to the C-terminal fragment of alpha-MSH, examined in laboratory models of inflammatory signaling and cellular transport pathways.
Examining how this peptide fragment interacts with inflammatory-pathway markers in controlled models.
Composition & Technical Specifications
Product Overview
KLOW is a proprietary four-peptide research formulation developed to support scientific investigation into multiple biological pathways within a single experimental model. This laboratory blend combines BPC-157, TB-500, GHK-Cu, and KPV, four extensively studied research peptides selected for their distinct molecular characteristics and complementary areas of investigation. Researchers utilize combination peptide formulations to explore cellular communication, extracellular matrix biology, tissue remodeling, inflammatory signaling, and peptide interaction within controlled laboratory environments. By combining multiple compounds into one formulation, investigators can examine both individual peptide properties and their behavior within complex experimental systems.
Blend Composition
GHK-Cu — 50 mg Glycyl-L-Histidyl-L-Lysine Copper GHK-Cu is a naturally occurring copper-binding peptide recognized for its extensive body of published research. Scientific studies have explored its involvement in extracellular matrix biology, collagen synthesis, cellular signaling, gene expression, and connective tissue remodeling. Because of its broad range of documented biological activity, GHK-Cu remains one of the most widely researched peptides in regenerative biology. BPC-157 — 10 mg BPC-157 is a synthetic research peptide that has been investigated across numerous preclinical laboratory models. Research has examined its relationship with angiogenic signaling pathways, connective tissue biology, gastrointestinal research, and cellular protection mechanisms observed in controlled experimental systems. TB-500 — 10 mg TB-500 is a synthetic fragment associated with thymosin beta-4 research. It has been studied for its role in cell migration, actin regulation, angiogenesis, and tissue-remodeling pathways in preclinical laboratory models. KPV — 10 mg KPV is a tripeptide (Lys-Pro-Val) corresponding to the C-terminal fragment of alpha-MSH. Laboratory research has examined its involvement in inflammatory signaling and cellular transport pathways within controlled research environments.